PACIFICPHARMA CORPORATION – Trademark Portfolio
Entity Type: 03
PACIFICPHARMA CORPORATION holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THERACNE. The owner is based in Seoul.
175-2, Hangangro 2-ga, Yongsangu
Seoul 140-871 , KR
Showing of trademarks Trademarks
Trademark Classifications
PACIFICPHARMA CORPORATION's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does PACIFICPHARMA CORPORATION have?
PACIFICPHARMA CORPORATION has 12 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 cancelled.
What trademark classes does PACIFICPHARMA CORPORATION file in?
PACIFICPHARMA CORPORATION files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are PACIFICPHARMA CORPORATION's most well-known trademarks?
PACIFICPHARMA CORPORATION's registered trademark portfolio includes well-known marks such as THERACNE. These are among 1 currently registered trademark in the portfolio.
What is PACIFICPHARMA CORPORATION's trademark registration success rate?
PACIFICPHARMA CORPORATION has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.